市場調查報告書
商品編碼
1467844
2024-2032 年按組件、方式、應用、最終用戶和地區分類的輻射劑量管理市場Radiation Dose Management Market by Component, Modality, Application, End User, and Region 2024-2032 |
IMARC Group年,全球輻射劑量管理市場規模達3.072億美元。廣泛的研發(R&D)活動、醫療保健行業的不斷成長以及癌症等慢性病發病率的增加是推動市場發展的一些關鍵因素。
輻射劑量管理是指透過屏障或電腦斷層掃描 (CT) 減少技術來最佳化、調節或阻止劑量的醫療系統。它包括用於監測患者暴露、最佳化、品質保證、劑量管理和即時工作人員劑量監測的工具資訊。它為放射技師、醫生、醫學物理專家 (MPE) 和其他涉及影像的健康專業人員提供幫助。輻射劑量管理有助於促進輻射劑量相關資訊的資料收集和處理、統計比較、報告和管理。因此,輻射劑量管理系統廣泛應用於醫院、影像中心和研究機構,用於估計手術所需的劑量,以防止病患受到高輻射劑量照射。
全球診斷成像方式的使用不斷增加是推動市場成長的關鍵因素之一。輻射劑量管理有助於自動收集和整合成像方式產生的大量劑量資料。與此一致的是,該技術在超音波、磁振造影 (MRI)、電腦斷層掃描 (CT)、正子斷層掃描 (PET) 和 X 光成像中的廣泛採用有利於市場成長。此外,擴大利用輻射劑量管理來識別、分析和處理重大劑量事件以及導出劑量資料進行報告,這是另一個成長誘導因素。除此之外,人工智慧(AI)和物聯網(IoT)的整合可以獲得患者所接受的輻射劑量的即時資訊並提高安全性,這為市場成長提供了動力。此外,輻射劑量管理的廣泛使用,透過追蹤輻射暴露歷史來幫助提高患者安全,正在推動市場成長。此外,由於輻射劑量管理具有眾多優點,例如減輕了在中心進行的 CT 手動收集劑量的負擔以及及早發現錯誤的劑量選擇,因此對輻射劑量管理的需求不斷增加,正在對市場成長產生積極影響。除此之外,由於劑量管理系統功效的提高,政府採取了各種鼓勵劑量管理系統的舉措,為市場創造了積極的前景。其他因素,包括消費者支出能力的提高、廣泛的研發(R&D)活動、醫療保健行業的顯著擴張、癌症等慢性病發病率的增加以及對輻射劑量管理的認知不斷增強,預計將推動市場的發展進一步成長。
The global radiation dose management market size reached US$ 307.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 896.3 Million by 2032, exhibiting a growth rate (CAGR) of 12.3% during 2024-2032. Extensive research and development (R&D) activities, escalating growth in the healthcare industry, and increasing incidences of chronic diseases, such as cancer, represent some of the key factors driving the market.
Radiation dose management refers to a medical system used to optimize, regulate, or block doses through barriers or computed tomography (CT) reduction technologies. It includes information of tools for monitoring patient exposure, optimization, quality assurance, dose management, and real-time staff dose monitoring. It helps radiographers, medical practitioners, medical physics experts (MPE), and other health professionals involved in imaging. Radiation dose management assists in facilitating data collection and processing, statistical comparisons, reporting, and management of radiation dose-related information. As a result, radiation dose management systems are widely used in hospitals, imaging centers, and research institutes for estimating the dose required for a procedure to prevent high radiation dose exposure to patients.
The increasing utilization of diagnostic imaging modalities across the globe is one of the key factors driving the market growth. Radiation dose management helps in automatically gathering and consolidating the large amounts of dose data generated by imaging modalities. In line with this, the widespread adoption of the technique in ultrasound, magnetic resonance imaging (MRI), computer tomography (CT), positron emission tomography (PET), and X-ray imaging is favoring the market growth. Moreover, the increasing utilization of radiation dose management for identifying, analyzing, and processing significant dose events and exporting dose data for reporting is acting as another growth-inducing factor. Apart from this, the integration of artificial intelligence (AI) and the Internet of Things (IoT) that allows to obtain real-time information on the radiation dose received by patients and improving safety is providing an impetus to the market growth. Additionally, the widespread utilization of radiation dose management, which assists in increasing patient safety by tracking radiation exposure history, is propelling the market growth. Furthermore, the increasing demand for radiation dose management due to its numerous advantages, such as reduced burden of manual collection of doses for CT performed in a center and the early detection of wrong dose selection, is positively influencing the market growth. Besides this, the implementation of various government initiatives to encourage dose management systems due to their increased efficacy is creating a positive outlook for the market. Other factors, including rising expenditure capacities of consumers, extensive research and development (R&D) activities, significant expansion in the healthcare industry, increasing incidences of chronic diseases, such as cancer, and growing awareness about radiation dose management, are anticipated to drive the market growth further.
IMARC Group provides an analysis of the key trends in each segment of the global radiation dose management market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on component, modality, application and end user.
Software
Integrated Solution
Standalone Solution
Services
The report has provided a detailed breakup and analysis of the radiation dose management market based on the component. This includes software (integrated and standalone solution) and services. According to the report, software represented the largest segment.
Computed Tomography
Fluoroscopy and Interventional Imaging
Radiography and Mammography
Nuclear Medicine
The report has provided a detailed breakup and analysis of the radiation dose management market based on the modality. This includes computed tomography, fluoroscopy and interventional imaging, radiography, and mammography, and nuclear medicine. According to the report, computed tomography represented the largest segment.
Oncology
Cardiology
Orthopedic Applications
Others
The report has provided a detailed breakup and analysis of the radiation dose management market based on the application. This includes oncology, cardiology, orthopedic applications, and others. According to the report, oncology represented the largest segment.
Hospitals
Ambulatory Care Setting
Others
The report has provided a detailed breakup and analysis of the radiation dose management market based on the end user. This includes hospitals, ambulatory care settings, and others. According to the report, hospitals represented the largest segment.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for radiation dose management. Some of the factors driving the North America radiation dose management market included growing awareness about radiation dose management, extensive research and development (R&D) activities, and various technological innovations.
The report has also provided a comprehensive analysis of the competitive landscape in the global radiation dose management market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Bayer Pharmaceuticals (Bayer AG), General Electric Company, INFINITT Healthcare Co. Ltd., Koninklijke Philips N.V., Medsquare, Novarad Corporation, PACSHealth LLC, Qaelum, Sectra AB, Siemens Healthcare Private Limited (Siemens AG), Volpara Health Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.